Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma. | J Enzyme Inhib Med Chem | 2023 | 37096557 | PubTator, text mining | PubMed |
| Discovery of novel, potent, and orally bioavailable HDACs inhibitors with LSD1 inhibitory activity for the treatment of solid tumors. | Eur J Med Chem | 2023 | 37086699 | PubTator, text mining | PubMed |
| 3D genome mapping identifies subgroup-specific chromosome conformations and tumor-dependency genes in ependymoma. | Nat Commun | 2023 | 37085539 | PubTator, text mining | PubMed |
| Phytochemistry and pharmacology of natural prenylated flavonoids. | Arch Pharm Res | 2023 | 37055613 | PubTator, text mining | PubMed |
| Macrocyclic Octapeptide Binding and Inferences on Protein Substrate Binding to Histone Deacetylase 6. | ACS Chem Biol | 2023 | 37027789 | PubTator, text mining | PubMed |
| Downregulation of histone deacetylase 8 (HDAC8) alleviated the progression of oral submucous fibrosis. | J Dent Sci | 2023 | 37021220 | PubTator, text mining | PubMed |
| Roles of histone acetylation sites in cardiac hypertrophy and heart failure. | Front Cardiovasc Med | 2023 | 37008337 | PubTator, text mining | PubMed |
| Trained immunity: A "new" weapon in the fight against infectious diseases. | Front Immunol | 2023 | 36993966 | PubTator, text mining | PubMed |
| Trio RNA sequencing in a cohort of medically complex children. | Am J Hum Genet | 2023 | 36990084 | PubTator, text mining | PubMed |
| 2-Aminobenzothiazoles in anticancer drug design and discovery. | Bioorg Chem | 2023 | 36989736 | PubTator, text mining | PubMed |
| Nitrile Oxide, Alkenes, Dipolar Cycloaddition, Isomerization and Metathesis Involved in the Syntheses of 2-Isoxazolines. | Molecules | 2023 | 36985520 | PubTator, text mining | PubMed |
| Exploring the Potential of Phytocompounds for Targeting Epigenetic Mechanisms in Rheumatoid Arthritis: An In Silico Study Using Similarity Indexing. | Molecules | 2023 | 36985402 | PubTator, text mining | PubMed |
| Metastasis in Neuroblastoma and Its Link to Autophagy. | Life (Basel) | 2023 | 36983973 | PubTator, text mining | PubMed |
| Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. | Int J Mol Sci | 2023 | 36982651 | PubTator, text mining | PubMed |
| Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. | Int J Mol Sci | 2023 | 36982453 | PubTator, text mining | PubMed |
| Forward Genetics-Based Approaches to Understanding the Systems Biology and Molecular Mechanisms of Epilepsy. | Int J Mol Sci | 2023 | 36982355 | PubTator, text mining | PubMed |
| Epigenetic Regulation of β-Globin Genes and the Potential to Treat Hemoglobinopathies through Epigenome Editing. | Genes (Basel) | 2023 | 36980849 | PubTator, text mining | PubMed |
| New Approaches to Targeting Epigenetic Regulation in Bladder Cancer. | Cancers (Basel) | 2023 | 36980741 | PubTator, text mining | PubMed |
| Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC). | Cancers (Basel) | 2023 | 36980655 | PubTator, text mining | PubMed |
| Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review. | Children (Basel) | 2023 | 36980059 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=21